Tina Hsu (@THsuMD) profile picture

Medical oncologist, Geriatric Oncologist, Researcher, Educator, Clinician and Avid Figure Skater. Retweets and likes do not mean endorsement.

Canada
Joined April 2013
Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)Photo by Tina Hsu (@THsuMD)
Congratulations to @vani_katheria on a fantastic presentation! Proud to be part of this program and to support this important study in Brazil 🇧🇷 @myCARG @WilliamDale_MD #GOTO #SIOG2025 #SIOG25 @SIOGorg
9
2
13
2,882
🚨New @ASCO Guideline Alert! 🌍 Honored to have worked alongside @EnriqueSoto8 & cols in developing this guideline Check out the latest recommendations on GA, designed to improve care worldwide 📄Full guideline: ascopubs.org/doi/pdf/10.1200… 🎙️Don’t miss the accompanying podcast!
7
29
5
77
12,413
Tina Hsu retweeted
We are hosting the next Canadian Geriatric Oncology Conference in beautiful Vancouver!!! We have an exciting agenda for the day ranging from how to implement and sustain geriatric oncology at your centre to our ever popular geriatric assessment workshop! #gerionc
Nearly 60% of new cancer cases in Canada occur in older adults. The 2025 Canadian Geriatric Oncology Conference is your chance to get practical, evidence-based strategies for their care. 🧠 Expert-led. Patient-focused. Save your seat: ow.ly/R4lP50WpjAu #CGOC25 #MedOnc
2
1
2
372
#ASCO25 #plenary If the graph on the left is practice changing, the graph on the right is urgently practice changing. Cost to health systems-$15K to $18K a month vs $100-$150 a month. ATOMIC trial vs CHALLENGE trial.
1
50
6
178
16,064
#ASCO25 @ASCO @NEJM ✅ Exercise Saves Lives After Colon Cancer ➡️ come watch Dr Chris Booth present the results of the ph3 CO.21 CHALLENGE study - don’t walk, run! 🏃🏃🏻‍♂️🏃 Hall B1 430-6pm 🙏 to our patients, my GI group @CDNCancerTrials 🇨🇦 and our partner @GICancer 🇦🇺🇳🇿for sticking with this trial over the past 15 years! #trialsthatmatter
4
26
3
81
7,278
ATTN @CAMO_ACOM MO members & trainees 🇨🇦 👇invite you to check out our Biennial Report report 📝…and see what CAMO has been doing to advance our mission of empowering you to advance cancer care 🌼 👋 if you’re a 🇨🇦 MO & not a member - pls DM me, happy to send u a copy & invite you to become a member!
🚨The @CAMO_ACOM 2023-2024 Biennial Report is now available for members. Dive into the report to explore our progress, ongoing projects, and a look ahead to what’s next - a must-read📖 💻camo-acom.ca/Members @GillSharlene @Erin19785799 @camoprez @drdaviddawe
1
3
6
1,103
When facing tradeoffs, many older patients prefer not to sacrifice cognition and function for living longer. We need to measure these outcomes in trials and research to help older adults decide what benefits to pursue and what risks to take. @myCARG @WilliamDale_MD @EnriqueSoto8
Replying to @EnriqueSoto8
An essential outcome: 🧠82% said they would rather maintain their cognition than live as long as possible 💪60% said they would rather live a shorter live than lose their ability to take care of themselves #gerionc #gerieheme doi.org/10.1002/cncr.35333
7
15
1,981
🌟Thrilled to extend our heartfelt congrats to the well-deserving winner of the 2024 #ASCO BJ Kennedy Geriatric Oncology Award @WilliamDale_MD! Your impactful contributions to the field of #GeriOnc are inspiring. Keep up the incredible work! Read More: bit.ly/3xcsDTM
10
12
3
48
3,097
What matters to #older #cancer #survivors? 1️⃣Close social relationships 2️⃣ HRQOL 3️⃣ Functional Independence These outcomes need to be considered for how we measure quality cancer care. #CancerRehab professionals are skilled to address each of these priorities. #SIOG2023
1
10
25
1,538
Crucial distinctions: 1. Decision-making 2. Capacity 3. Competency 4. Informed consent Every provider in #GeriOnc needs to know the differences! #SIOG2023 – at Valencia, Spain
1
2
6
301
Always great to catch up with the amazing @montypal #ASCO23
2
2
1
17
3,222
Do not miss watching this session if you aren’t already here. Rockstar line up and mega pearls on Geri Onc implementation! @OncElias @THsuMD @GeriOncCoP
3
5
21
853
Replying to @THsuMD
@THsuMD @andrewchap361 @OncElias, sharing experiences leading translation of #GA into practice… and sustaining it. Tailor to local resources, appeal to key stakeholders, get feedback and adapt… Just do it. #ASCO23 @WilliamDale_MD @myCARG @ASCO @SIOGorg @AmerGeriatrics
1
7
17
658
Check out our @ASCO Ed Book article "Management of #prostate #cancer in older adults"! Practical tips on #gerionc risk assessment, interventions to improve tx tolerance, and decision-making in era of novel treatments. ascopubs.org/doi/full/10.120… #pcsm #ASCO23 @myCARG @PCF_Science
1
16
1
44
8,116
Tina Hsu retweeted
By 2040, nearly 3/4ths of cancer survivors in the U.S. will be older than 65. Find out how to prep for this 'silver oncologic tsunami' at #ASCO23: fal.cn/3y3UZ #ASCODailyNews #GeriOnc @andrewchap361 @THsuMD @OncElias
8
2
17
11,045
Well done @RachelGoodwinMD with early opening #CAMO23 breakfast symposium @OttawaMedOnc
3
16
574
“If you don’t get rejected once, you didn’t aim high enough.” @LaraVarpio @ICREConf Get rejected first!
2
6
“You can’t make everyone happy. You’re not pizza.” @holly_cw and @LaraVarpio and the importance of talking about failure in Med Ed @ICREConf
1
7
1
29
CBME results in MORE feedback - I buy that. I’m less convinced it has resulted in IMPROVED feedback. Is the quality and usefulness improving? I hope so…but am unsure. #ICRE2022
15
21
6
130
What do hematology residents know about caring for older adults with cancer? A National Survey of Canadian hematology residents' knowledge and interests geriatriconcology.net/articl… @THsuMD @HiraSMian @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG
9
1
21